Prelude Therapeutics Incorporated ( PRLD) - Key Metrics
PRLD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.09 | -$0.26 | $0.37 | $0.37 |
| 2025Q3 | $0.09 | -$0.26 | -$0.25 | -$0.25 |
| 2025Q2 | ? | -$0.41 | -$0.34 | -$0.34 |
| 2025Q1 | ? | -$0.42 | -$0.45 | -$0.45 |
PRLD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.77 |
| 2025Q3 | ? | -1.39 |
| 2025Q2 | ? | -0.49 |
| 2025Q1 | ? | -0.45 |
PRLD
Price: $4.20
52 week price:
Earnings Per Share: -1.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65500
Market Capitalization: 216.9 million